Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer

NCT01419717 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01419717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01419717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Access Protocol of Denosumab for Subjects With Advanced Cancer
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
November 22, 2011
Completion date
August 10, 2018
Enrollment
129 (actual)
Sites
64

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases in men with hormone-refractory prostate cancer, bone metastases in subjects with advanced breast cancer